Back Page - Pharmaceutical Executive

ADVERTISEMENT

Back Page
A pharma miscellany.

FDA Abroad

July 21, 2014

FDA officials willing to relocate to far-flung global cities should be congratulated for their herculean efforts to protect American patients. But funding cuts hamper the Agency's international presence.

The Urge to Merge

June 9, 2014

Dealmaking lessons from history's storyboard.

Immunotherapies: The New Hope for Cancer Treatment

June 9, 2014

The Cancer Research Institute is clearing a path to the future of immunotherapeutics. Ben Comer speaks to its CEO and director of scientific affairs, Jill O'Donnell-Tormey

Brands of Yesteryear: Where Are They Now?

May 6, 2014

We check back with previous Pharm Exec Brand of the Year winners to see how things are going.

Sickle Cell Disease In Three Acts

April 22, 2014

Ben Comer reports on how new pipeline therapies, public research investments, and a renewed sociopolitical focus are working toward a happier outcome for sickle cell disease patients.

Biosimilars or Bust

January 21, 2014

Where are the biosimilars to help cut costs as the first wave of biologics, or complex, small molecule respiratory drugs, for example, go off patent? They've arrived in Europe, but the U.S. lags...

Brand vs. Generic: Physicians Weigh In

December 1, 2013

Why do some doctors prescribe more generic drugs than others?

Top Medical Innovations for 2014

November 1, 2013

At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.

Using Data to Influence Behavior and Predict Outcomes

October 1, 2013

Predictive analysis has been used to great effect in the finance, tech, retail, and telecoms industries. Can it also improve decision-making and health outcomes in life sciences?

ADVERTISEMENT

Click here